Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioatla Inc (NQ: BCAB ) 1.695 -0.115 (-6.35%) Streaming Delayed Price Updated: 11:42 AM EDT, Aug 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 609,292 Open 1.850 Bid (Size) 1.690 (10) Ask (Size) 1.700 (3) Prev. Close 1.810 Today's Range 1.660 - 1.860 52wk Range 1.140 - 4.020 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024 May 14, 2024 BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 14, 2024 Via Benzinga Performance YTD -36.04% -36.04% 1 Month +25.56% +25.56% 3 Month -49.70% -49.70% 6 Month -11.49% -11.49% 1 Year -41.15% -41.15% More News Read More 12 Health Care Stocks Moving In Thursday's Intraday Session May 02, 2024 Via Benzinga BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023 March 26, 2024 Via InvestorPlace BioAtla: Q4 Earnings Insights March 26, 2024 Via Benzinga Preview: BioAtla's Earnings March 25, 2024 Via Benzinga Analyst Ratings for BioAtla September 25, 2023 Via Benzinga The Latest Analyst Ratings for BioAtla August 02, 2023 Via Benzinga Earnings Scheduled For March 26, 2024 March 26, 2024 Via Benzinga Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying December 20, 2023 Via Benzinga Topics Stocks Exposures US Equities BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference December 20, 2023 From BioAtla, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session December 18, 2023 Via Benzinga BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event December 05, 2023 From BioAtla, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session December 04, 2023 Via Benzinga BioAtla to Participate in the JMP Securities Hematology and Oncology Summit November 30, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC November 28, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress November 07, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the Jefferies London Healthcare Conference November 06, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award October 12, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023 October 10, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Participate in Upcoming Investor Conferences in August August 03, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress August 01, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023 July 25, 2023 From BioAtla, Inc. Via GlobeNewswire BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index June 26, 2023 From BioAtla, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
